The predictive value of pretherapy [68Ga]Ga-DOTA-TATE PET and biomarkers in [177Lu]Lu-PRRT tumor dosimetry.

Purpose: Metastatic neuroendocrine tumors (NETs) overexpressing type 2 somatostatin receptors are the target for peptide receptor radionuclide therapy (PRRT) through the theragnostic pair of 68Ga/177Lu-DOTATATE. The main purpose of this study was to develop machine learning models to predict therape...

Descripción completa

Detalles Bibliográficos

Publicado en:	European Journal of Nuclear Medicine & Molecular Imaging Vol. 50; no. 10; pp. 2984 - 2997
Autores principales:	Akhavanallaf, Azadeh, Peterson, Avery B., Fitzpatrick, Kellen, Roseland, Molly, Wong, Ka Kit, El-Naqa, Issam, Zaidi, Habib, Dewaraja, Yuni K.
Formato:	Journal Article
Publicado:	Springer Nature Aug2023
Acceso en línea:	Ver este registro en EBSCOhost